TCL Archive ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications July 22, 2011
TCL Archive AICR Increasing Funds for Research, Education, Supports Successful Symposium November 7, 1986
TCL Archive Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules July 30, 1999
TCL Archive In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited September 10, 1976
